Innovations In Clinical Neuroscience

SEP-OCT 2014

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 78 of 201

[ V O L U M E 1 1 , N U M B E R 9 – 1 0 , S E P T E M B E R – O C T O B E R 2 0 1 4 ] Innovations in CLINICAL NEUROSCIENCE 79 48:987–996. 3. Oquendo MA, Halberstam B, Mann, JJ. Columbia suicide history form. In: Rush J, First MB, Black D (eds). Handbook of Psychiatric Measures, Vol. 2. Washington, DC: American Psychiatric Press Inc.; 2008:241–242 4. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164:1035–1043. 5. United States Food and Drug Administration, United States Department of Health and Human Services. Guidance for Industry: Suicidality: Prospective Assessment of Occurrence in Clinical Trials, Draft Guidance. September 2010. les/2010/09/09/2010-22404/draft- guidance-for-industry-on-suicidality- prospective-assessment-of- occurrence-in-clinical-trials. Accessed October 1, 2014. 6. United States Food and Drug Administration, United States Department of Health and Human Services. Guidance for Industry: Suicidality: Prospective Assessment of Occurrence in Clinical Trials, Draft Guidance. August 2012. Revision 1. gs/Guidances/UCM225130.pdf. Accessed October 1, 2014. 7. Roth M. Max Hamilton: a life devoted to psychiatry. In: Bech P, Coppen A (eds). The Hamilton Scales. Berlin: Springer-Verlag; 1990:1–9. 8. Worboys M. The Hamilton Rating Scale for Depression: The making of a ''gold standard'' and the unmaking of a chronic illness, 1960–1980. Chronic Illness. 2013;9(3):202–219. 9. Harkavy Friedman JM, Asnis GM. Assessment of suicidal behavior: a new instrument. Psychiatr Ann. 1989;19:382–387. 10. Lindenmayer JP1, Czobor P, Alphs L, et al. InterSePT Study Group. The InterSePT scale for suicidal thinking reliability and validity. Schizophr Res. 2003;63:161–170. 11. Osman A, Bagge CL, Gutierrez PM, et al. The Suicidal Behaviors Questionnaire-Revised (SBQ-R): validation with clinical and nonclinical samples. Assessment. 2001;8:443–454. 12. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47(2):343–352. 13. Coric V, Stock EG, Pultz J, et al. Sheehan Suicidality Tracking Scale (S-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont). 2009;6: 26–31. 14. Crosby A, Ortega L, Melanson C. Self-Directed Violence Surveillance: Uniform Definitions and Recommended Data Elements, version 1.0. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2011. 15. Center for Suicide Risk Assessment. About the C–SSRS. Columbia University Medical Center Website. http://www.cssrs. Accessed October 1, 2014. 16. Chappell P, Feltner DE, Makumi C, et al. Initial validity and reliability data on the Columbia–Suicide Severity Rating Scale. Letter to the Editor. Am J Psychiatry. 2012;169:662–663. 17. Brent DA, Emslie GJ, Clarke GN, et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry. 2009;166:418–426. 18. Mundt JC, Greist JH, Gelenberg AJ, et al. Feasibility and validation of a computer-automated Columbia–Suicide Severity Rating Scale using interactive voice response technology. J Psychiatr Res. 2010;44(16):1224–1228. 19. Gutierrez PM. Evaluation of existing psychometric data on the Columbia–Suicide Severity Rating Scale (C–SSRS): working paper for the Military Suicide Research Consortium. Florida State University. December 6, 2011. sites/default/files/MSRC_C–SSRS_ evaluation.pdf. Accessed October 1, 2014. 20. Vandepeer M. Health Policy Advisory Committee on Technology. Technology Brief. Columbia Suicide Severity Rating Scale. HealthPact Wmerging Health Technology. State of Queensland, Australia. August 2012. pact/docs/briefs/WP114.pdf. Accessed October 1, 2014. 21. Bagby RM, Ryder AG, Schuller DR, et al. The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight? Am J Psychiatr. 2004;161:2163–2177. 22. Alphs L. Assessment of suicidal ideation, behavior and risk. Presented to the Suicide Assessment Working Group at the 52 nd American College of Neuropsychopharmacology Annual Meeting. Hollywood, FL: December 2013. 23. Guilford JP. Fundamental Statistics in Psychology and Education, Fourth Edition. New York: McGraw-Hill; 1965. 24. Spector PE. Summated Rating Scale Construction: An Introduction. Sage University Papers. Series Quantitative Applications in the Social Sciences, 82. Newbury Park CA: Sage Publications;1992. 25. Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychologic Assess. 1995;7:309–319. 26. Haynes SN. Richard DCS, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychologic Assess. 1995;7.238–247. 27. Giddens JM, Sheehan DV. Do the five combinations of suicidal ideation in the FDA 2012 Draft

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - SEP-OCT 2014